Phase II trials of the single agents baker's antifol, diaziquone, and epirubicin in advanced pancreatic cancer. Gastrointestinal Tumor Study Group.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples